Alvotech Reiterates Meeting US Humira Biosimilar Launch Date
As Partner Cipla Bags Australian Approval For AVT02 Adalimumab Asset
Executive Summary
Recently public Alvotech had much to share as part of its nine-month financial report, including updates on adalimumab in the US and the process to begin biosimilar golimumab trials.